Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04837066 · ClinicalTrials.gov registry record
Dynamic Vision Testing and Concussion Management
A clinical trial, sponsored by California State University, Northridge.
- Completed
- Registry status
- 100
- Enrollment target
NCT04837066: Completed study, sponsored by California State University, Northridge.
NCT04837066 is a clinical trial that has completed, run by California State University, Northridge. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04837066 has completed, sponsored by California State University, Northridge.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the value of including dynamic vision testing into California State University, Northridge (CSUN) Athletics' established concussion protocol. The study's hypotheses are 1) dynamic vision testing will reveal vision impairments right after a person sustains a concussion, 2) these impairments may still be present upon clearance to return to play.
Primary Outcome
Number of errors and time subject was able to hold position
Interventions
- DIAGNOSTIC_TEST Dynamic Vision Testing (Bertec Vision Advantage System) and Balance Error Scoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-08-31 |
| Est. Completion | 2024-05-15 |
What the finished NCT04837066 record still lists
NCT04837066 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Dynamic Vision Testing (Bertec Vision Advantage System) and Balance Error Scoring System is the first listed.
NCT04837066 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04837066 about?
NCT04837066 is a clinical study titled "Dynamic Vision Testing and Concussion Management". The purpose of this study is to determine the value of including dynamic vision testing into California State University, Northridge (CSUN) Athletics' established concussion protocol. The study's hypotheses are 1) dynamic vision testing will reveal vision impairments right after a person sustains a ...
What is the current status of trial NCT04837066?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2021-08-31. Estimated completion is 2024-05-15.
What interventions are being tested in trial NCT04837066?
The interventions under investigation include: Dynamic Vision Testing (Bertec Vision Advantage System) and Balance Error Scoring System (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04837066?
This trial is sponsored by California State University, Northridge, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI